The Parker H. Petit Institute for Bioengineering and Bioscience has grown by one world-class researcher with the recent addition of Ravi Kane to its multidisciplinary community of scientists and engineers.
Kane is a brand new professor in the School of Chemical and Biomolecular Engineering (where he is the Kathy and Garry Betty Faculty Chair), having lately arrived at the Georgia Institute of Technology following 14 years at Rensselaer Polytechnic Institute, where he headed the Department of Chemical and Biological Engineering.
Before taking his career to Rensselaer, Kane served a post-doctoral fellowship at Harvard. He graduated with distinction from Stanford with a B.S. in chemical engineering and earned his graduate degrees in chemical engineering from the Massachusetts Institute of Technology (MIT).
Kane is interested in research at the interface of biotechnology and nanotechnology. His work has focused on the engineering of therapeutics (polyvalent molecules and viral gene delivery vectors) and the molecular engineering of bio-surfaces and nanostructures.
The addition of Kane brings the number of Petit Institute faculty to 173.
CONTACT:
Jerry Grillo
Communications Officer II
Parker H. Petit Institute for
Bioengineering and Bioscience
Media Contact
Jerry Grillo
Communications Officer II
Parker H. Petit Institute for
Bioengineering and Bioscience
Keywords
Latest BME News
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder
Researchers develop spatial transcriptomics toolkit that provides new insights into the molecular processes of life
Air Detectives take top prize to give department three straight victories in Expo competition
Coulter BME community gathers at the Fabulous Fox to celebrate anniversary of unique public-private partnership
Coskun pioneering new research area and building a company around iseqPLA technology
BME undergraduate student and competitive skater Sierra Venetta has found success on and off the ice
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients